Tesla suffers blow as Senate axes California EV mandate, Supreme Court makes Federal Reserve ruling, and more news to start your day.

WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas. NCCN joins the Infectious Disease Society of America (IDSA) that updated its COVID-19 guidelines in August 2024 to recommend the use of PEMGARDA (pemivibart) for pre-exposure prophylaxis (PrEP) in moderately to severely immunocompromised adults and adolescents (aged 12 or older) at risk for progression to severe COVID-19 when predominant regional variants are susceptible to pemivibart.

Demis Hassabis, the chief executive of Google DeepMind, says that “we're quite close” to human-level artificial intelligence. After that, all bets are off.

On May 18, 2025, NVIDIA Corp. NASDAQ: NVDA announced the latest updates and systems in its efforts to spur the development of humanoid robots. These tools, including new models for humanoid reasoning, motion, and skills, may contribute to what CEO Jensen Huang has described as the "next industrial revolution," made possible with physical AI and robotics.

Crude oil futures stall as traders target $59.51 support zone. OPEC+ output hike and U.S. inventory build reinforce a bearish oil outlook.

I rate Comfort Systems a Strong Buy with a fair value of $563, driven by robust demand in data centers and chip fabs. The company benefits from US manufacturing policy tailwinds and major tech investments, fueling organic growth and value-accretive acquisitions. Comfort Systems boasts accelerating revenue, record backlog, and margin expansion potential, supported by disciplined M&A and operating leverage.

KEARNEY, Neb.--(BUSINESS WIRE)--THE BUCKLE, INC. REPORTS FIRST QUARTER NET INCOME.

MCLEAN, Va.--(BUSINESS WIRE)---- $BAH #earnings--Booz Allen Hamilton (NYSE: BAH) today announced preliminary results for the fourth quarter and full fiscal year 2025.

TJX Companies reported solid fiscal 1Q'26 results that were not good enough to support the stock on earnings day. The management team sounded very upbeat about TJX's ability to navigate the tariff-related challenges ahead. What you see is what you get: TJX's growth is less than impressive, while the stock looks very richly priced. I am no longer a bull.

President Donald Trump is expected to sign executive orders that will be a boon to the nuclear energy.

WAB is benefiting from rising market demand, fueling its backlog growth. At the same time, the company's shareholder-friendly initiatives are commendable.

CF jumps 15% in a month as nitrogen demand climbs, prices rise and share buybacks boost investor value.

CALGARY, AB , May 23, 2025 /PRNewswire/ - Vermilion Energy Inc. ("Vermilion" or the "Company") (TSX: VET) (NYSE: VET) is pleased to announce that it has entered into a definitive agreement for the sale of its Saskatchewan and Manitoba assets (the "Assets") for cash proceeds of $415 million (the "Transaction"). Net proceeds from the Transaction will be directed towards debt repayment to accelerate deleveraging efforts and strengthen Vermilion's balance sheet.

HONG KONG , May 23, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE: DXF) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC ("NYSE American" or the "Exchange"). The Company failed to timely file its Form 20-F for the period ended December 31, 2024 (the "2024 Form 20-F") by the filing due date of May 15, 2025 (the "Filing Delinquency").

DENVER--(BUSINESS WIRE)--Modiv Industrial, Inc. (“Modiv Industrial”, “Modiv”, the “Company”, “we” or “our”), (NYSE:MDV), the only public REIT exclusively focused on acquiring industrial manufacturing real estate, today issued the following message from the CEO to provide clarity regarding the rationale and impact of the reverse stock proposal set forth in the Company's proxy statement for its 2025 Annual Meeting of Stockholders: “A few weeks ago, we filed our 2025 annual proxy statement. We hav.

HOUSTON and LONDON, May 23, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced its board of directors has declared a quarterly dividend of $1.37 per share, representing a $0.03 per share increase over the company's first quarter 2025 dividend. The dividend will be paid to shareholders on June 9, 2025, with an ex-dividend and record date of June 2, 2025.

ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of an underwritten public offering of 9,285,714 shares of its common stock, together with accompanying warrants to purchase 18,571,428 shares of its common stock. The combined public offering price of common stock and accompanying warrant is $1.40. The common stock is being sold in combination with an accompanying warrant to purchase two shares of common stock issued for each share of common stock sold. The …

Switzerland's supreme court on Friday ruled against a compensation claim by two former shareholders of Credit Suisse who bought stock in the bank shortly before it failed in March 2023, saddling them with hefty losses.

Shares of Exelixis, Inc. (EXEL), an oncology-focused biopharmaceutical firm, boosted by Big Money inflows.

The maker of Hoka sneakers declines to provide a fiscal 2026 outlook, citing macro uncertainty.